Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review
May 08, 2024 07:25 ET
|
ALTERITY THERAPEUTICS LIMITED
- ATH434-201 Trial on Track to Complete in November 2024 – - Top-Line Data Expected in January 2025 - MELBOURNE, Australia and SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) --...
Atlantica Reports First Quarter 2024 Financial Results
May 08, 2024 07:23 ET
|
Atlantica Sustainable Infrastructure plc
Revenue for the first quarter of 2024 remained stable at $242.9 million, compared with $242.5 million in the first quarter of 2023.Adjusted EBITDA was $164.2 million, a 0.9%1 year-over-year decrease...
WTW boosts global cyber facility with increased capacity and broader coverage options
May 08, 2024 07:16 ET
|
Willis Towers Watson US LLC
LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company, today announces strategic enhancements to its global cyber facility. Following a...
Gilat Reports First Quarter 2024 Results
May 08, 2024 07:05 ET
|
Gilat Satellite Networks Ltd.
PETAH TIKVA, Israel, May 08, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (NASDAQ: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions and services, today...
Celcuity Inc. Schedules Release of First Quarter 2024 Financial Results and Webcast/Conference Call
May 08, 2024 07:05 ET
|
Celcuity Inc.
MINNEAPOLIS, May 08, 2024 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it...
Vertex Announces First Quarter 2024 Financial Results
May 08, 2024 07:02 ET
|
Vertex Inc.
KING OF PRUSSIA, Pa., May 08, 2024 (GLOBE NEWSWIRE) -- Vertex, Inc. (NASDAQ: VERX) (“Vertex” or the “Company”), a leading global provider of indirect tax solutions, today announced financial results...
Olema Oncology Announces New Clinical Data for Palazestrant in Combination with Ribociclib to be Presented at the 2024 ESMO Breast Cancer Annual Congress
May 08, 2024 07:02 ET
|
Olema Oncology
SAN FRANCISCO, May 08, 2024 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery,...
SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference
May 08, 2024 07:00 ET
|
SpringWorks Therapeutics, Inc.
STAMFORD, Conn., May 08, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a commercial-stage biopharmaceutical company focused on severe rare diseases and cancer, today...
GDS to Report First Quarter 2024 Financial Results Before the Open of the U.S. Market on May 22, 2024
May 08, 2024 07:00 ET
|
GDS Holdings Limited
SHANGHAI, China, May 08, 2024 (GLOBE NEWSWIRE) -- GDS Holdings Limited (“GDS Holdings”, “GDS” or the “Company”) (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high-performance data...
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
May 08, 2024 07:00 ET
|
Verve Therapeutics
First patient dosed in Heart-2 Phase 1b clinical trial of VERVE-102 VERVE-201 clinical trial initiation on track for the second half of 2024 Received first milestone payment from Eli Lilly for...